Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

GKB Ophthalmics

GKB
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

GKB Ophthalmics Share price and Fundamental Analysis

View All Details
View All Details
Incorporated in Dec.'81 as a public limited company, GKB Opthalmics was granted a licence as a 100% EOU in 1982. The company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Ltd and The Maharashtra State Financial Corporation. It was promoted by K G Gupta, K M Gupta, B K Gupta and Ravi Gupta.
Company Incorporation1981
ChairmanK G Gupta
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
39.02
PE Ratio
0
Industry P/E
37.63
PEG Ratio
0
ROE
-13.54%
ROCE
-6.55%
ROA
-6.25%
Total Debt (Cr)
14.49
Debt to Equity
0.28
Dividend Yield
0%
EPS
0
Book Value & P/B
103.24 x 0.75
Face Value
10
Outstanding Shares(Cr)
0.5
Current Ratio
1.95
EV to Sales
0.34

Included In

+More

Stock Returns

1 Week-2.38%
1 Month+3.23%
6 Months-6.7%
1 Year-33.26%
3 Years-19.02%
5 Years+33.94%
no_data

No Stocks

Smart Score

2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Jun 25

Promoters : 51.06%

FIIs : 1.79%

DIIs : 0.00%

Public : 47.16%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in June 2025 Qtr
Promoter Shareholding Increased by 0.07% to 51.06% in June 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

GKB Ophthalmics Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

GKB Ophthalmics Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Incorporated in Dec.'81 as a public limited company, GKB Opthalmics was granted a licence as a 100% EOU in 1982. The company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Ltd and The Maharashtra State Financial Corporation. It was promoted by K G Gupta, K M Gupta, B K Gupta and Ravi Gupta.

The company is engaged in the manufacture and export of high-quality, single-vision mineral opthalmic lenses. Commercial production commenced in May '83. It has an installed capacity of 30 lac lenses pa. The company completed the expansion programme by expanding the capacity of single vision lenses to 33 lac pcs pa. It also installed facilities for coating 1.72 lac pcs of lenses pa. The above project was completed at a new loacation -- Pilerne Industrial Estate, Bardez-Goa. The company has shifted the single vision plant to the new premises in phases. In 1996-97, it increased the installed capacity of ophthamal lenses by 9,00,000 nos to 30,00,000 nos.

The company had floated a wholly owned subsidiary (WOS) at Bermen, Germany which acts as a stock point and have proper liasion with the buyers in and around Europe. To utilise its full capacity the company is planning to take a new shed which is adjacent to the current factory area, and the total area of the new shed is 1656 sq.mtrs. The associate company viz GKB Vision is performing well and has reported a healthy turnover. GKB ophthalmics ltd has made a substantial investment in the associated company.

GKB Ophthalmics Share Price

GKB Ophthalmics share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

GKB Ophthalmics Market Cap

Market capitalization of GKB Ophthalmics indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how GKB Ophthalmics is valued compared to its competitors.

GKB Ophthalmics PE Ratio

GKB Ophthalmics PE ratio helps investors understand what is the market value of each stock compared to GKB Ophthalmics 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

GKB Ophthalmics PEG Ratio

The PEG ratio of GKB Ophthalmics evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

GKB Ophthalmics ROE (Return on Equity)

Return on Equity (ROE) measures how effectively GKB Ophthalmics generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

GKB Ophthalmics ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of GKB Ophthalmics in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

GKB Ophthalmics Total Debt

Total debt of GKB Ophthalmics shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

GKB Ophthalmics Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of GKB Ophthalmics compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

GKB Ophthalmics CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of GKB Ophthalmics over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

GKB Ophthalmics Technical Analysis

Technical analysis of GKB Ophthalmics helps investors get an insight into when they can enter or exit the stock. Key components of GKB Ophthalmics Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where GKB Ophthalmics shares often struggle to rise above due to selling pressure.

GKB Ophthalmics Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect GKB Ophthalmics ’s financial health and profitability.

GKB Ophthalmics Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

GKB Ophthalmics Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

GKB Ophthalmics Financials

The financials of GKB Ophthalmics provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

GKB Ophthalmics Profit and Loss Statements

The profit and loss statement of GKB Ophthalmics highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of GKB Ophthalmics .

GKB Ophthalmics Balance Sheet

The balance sheet presents a snapshot of GKB Ophthalmics ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

GKB Ophthalmics Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.